Felley-Bosco E - Search Results

1

Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.

Meerang M, Bérard K, Friess M, Bitanihirwe BK, Soltermann A, Vrugt B, Felley-Bosco E, Bueno R, Richards WG, Seifert B, Stahel R, Weder W, Opitz I. Meerang M, et al. Mol Oncol. 2016 Oct;10(8):1255-65. doi: 10.1016/j.molonc.2016.06.005. Epub 2016 Jun 25. Mol Oncol. 2016. PMID: 27378628 Free PMC article.

2

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.

Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel RA. Belyanskaya LL, et al. Mol Cancer. 2007 Oct 22;6:66. doi: 10.1186/1476-4598-6-66. Mol Cancer. 2007. PMID: 17953743 Free PMC article.

3

Functional inactivation of NF2/merlin in human mesothelioma.

Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E. Thurneysen C, et al. Lung Cancer. 2009 May;64(2):140-7. doi: 10.1016/j.lungcan.2008.08.014. Epub 2008 Oct 4. Lung Cancer. 2009. PMID: 18835652

4

Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.

Ampollini L, Soltermann A, Felley-Bosco E, Lardinois D, Arni S, Speck RF, Weder W, Opitz I. Ampollini L, et al. Eur J Cardiothorac Surg. 2009 Mar;35(3):457-62. doi: 10.1016/j.ejcts.2008.11.030. Epub 2009 Jan 21. Eur J Cardiothorac Surg. 2009. PMID: 19162494 Free article.

5

Malignant pleural mesothelioma.

Stahel RA, Felley-Bosco E, Opitz I, Weder W. Stahel RA, et al. Future Oncol. 2009 Apr;5(3):391-402. doi: 10.2217/fon.09.7. Future Oncol. 2009. PMID: 19374545 Review.

6

Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.

Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H, Weder W, Stahel RA, Felley-Bosco E. Sidi R, et al. Eur J Cancer. 2011 Jan;47(2):326-32. doi: 10.1016/j.ejca.2010.09.044. Epub 2010 Oct 29. Eur J Cancer. 2011. PMID: 21036600

7

Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model.

Shi Y, Hollenstein A, Felley-Bosco E, Fraefel C, Ackermann M, Soltermann A, Weder W, Stahel R, Pruschy M, Opitz I. Shi Y, et al. Lung Cancer. 2011 Mar;71(3):370-1. doi: 10.1016/j.lungcan.2010.12.020. Epub 2011 Jan 31. Lung Cancer. 2011. PMID: 21277037 No abstract available.

8

Pleural mesothelioma side populations have a precursor phenotype.

Frei C, Opitz I, Soltermann A, Fischer B, Moura U, Rehrauer H, Weder W, Stahel R, Felley-Bosco E. Frei C, et al. Carcinogenesis. 2011 Sep;32(9):1324-32. doi: 10.1093/carcin/bgr127. Epub 2011 Jul 5. Carcinogenesis. 2011. PMID: 21729925 Free article.

9

Proteomic surfaceome analysis of mesothelioma.

Ziegler A, Cerciello F, Bigosch C, Bausch-Fluck D, Felley-Bosco E, Ossola R, Soltermann A, Stahel RA, Wollscheid B. Ziegler A, et al. Lung Cancer. 2012 Feb;75(2):189-96. doi: 10.1016/j.lungcan.2011.07.009. Epub 2011 Aug 10. Lung Cancer. 2012. PMID: 21835491 Free article.

10

Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.

Knobel PA, Kotov IN, Felley-Bosco E, Stahel RA, Marti TM. Knobel PA, et al. Neoplasia. 2011 Oct;13(10):961-70. doi: 10.1593/neo.11828. Neoplasia. 2011. PMID: 22028621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters